# Efficacy of Oral Semaglutide in Overweight or Obesity

> **NCT05442450** · PHASE4 · UNKNOWN · sponsor: **Asian Institute of Gastroenterology, India** · enrollment: 116 (estimated)

## Conditions studied

- Obesity
- Weight Loss

## Interventions

- **DRUG:** oral semaglutide

## Key facts

- **NCT ID:** NCT05442450
- **Lead sponsor:** Asian Institute of Gastroenterology, India
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-10
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 116 (ESTIMATED)
- **Last updated:** 2022-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05442450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05442450, "Efficacy of Oral Semaglutide in Overweight or Obesity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05442450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*